Healthcare / Medical Care FacilitiesSES
$0.06
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-3.2M · quality 44.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
28/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$18M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-49.9%
↓Gross Margin
38.1%
↓Debt/Equity
0.43
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-29.8%
FCF CAGR
—
FCF margin
-22.9%
FCF / Net income
0.69x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $14.0M · net income $-4.7M · FCF $-3.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $14.0M | $14.0M | $13.4M | $19.1M | $40.6M |
| Net Income | $-4.7M | $-4.7M | $-2.3M | $-5.4M | $-11.8M |
| EBITDA | $-4.8M | $-4.8M | $-3.1M | $2.1M | $-6.1M |
| EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 |
| Gross Margin | 38.1% | 38.1% | 32.4% | 28.2% | 16.5% |
| Operating Margin | -40.3% | -40.3% | -42.4% | -22.6% | -12.0% |
| Net Margin | -33.2% | -33.2% | -17.4% | -28.2% | -29.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.43 | 0.43 | 0.26 | 0.41 | 0.70 |
| Current Ratio | 1.08 | 1.08 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-3.2M | $-3.2M | $-8.3M | $423000.00 | $-2.1M |
| Returns | |||||
| ROE | -49.9% | -49.9% | -17.9% | -34.1% | -57.6% |
| Valuation | |||||
| EV/EBITDA | — | — | — | 4.75 | — |
| P/B | 1.86 | 1.86 | 1.22 | 1.19 | 0.70 |
| Growth & Yield | |||||
| Revenue Growth | 5.0% | 5.0% | -30.1% | -52.9% | — |
| EPS Growth | -96.0% | -96.0% | 57.9% | 55.8% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+61.8%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.01 → -0.01
Residual
+61.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.